ARCHIVES

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Cancer Act renewal, Appropriations Bill Caught In Squeeze Between Conventions

August 1, 1980

In Brief: Metcalf, Sachs, Nowell, Rowley, Elkind Win 1989 GM Award; Ray Morrison Retires

June 16, 1989

NTP Committee Finds Five Test Reports Show “Limited” Evidence Of Carcinogenicity

February 27, 1981

Obituary: Michale Keeling, of M.D. Anderson.

January 2, 2004

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014

ORI Clears Los Angeles Physician Of Misconduct In NSABP Participation

June 16, 1995